Science AI Journal
Medicine · Research topic

Open research questions in Sirtuins and Resveratrol in Medicine

27 unresolved questions extracted from the limitations and future-work sections of 164 Sirtuins and Resveratrol in Medicine papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Sirtuin-1 (SIRT1) is a NAD⁺-dependent deacetylase with antioxidant and anti-apoptotic properties, but its role in OxyHb-mediated neuronal injury remains incompletely defined.

    SIRT1 Attenuates Oxyhemoglobin-Induced Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Neuronal Cells · 2026 · DOI

  • Rationale The acetylation level of XRCC6 is significantly decreased in clinical breast cancer tissues compared with paracancerous tissues; however, the relationship between this alteration and the occurrence and development of breast cancer remains unclear.

    SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression · 2026 · DOI

  • Despite the comprehensive evaluation of CBZ-induced car- diotoxicity and the potential protective effects of resveratrol, several limitations should be acknowledged. The sample size was relatively small, which may have limited the statis- tical power to detect minor functional changes, particularly in echocardiographic and IVPG parameters. However, post hoc effect size and power analyses were performed, indicat- ing adequate statistical power for the study results, support- ing the reliability of the findings. The absence of a dedicated vehicle control group represents a potential limitation; however, the solvent concentration used was within ranges accepted in scientific research. Intracardiac catheterization was not performed to obtain direct hemodynamic measure- ments. Detailed inflammatory or coagulation biomarkers were not assessed, which could provide further insight into the mechanisms underlying cardiac and hematological alter- ations. The short duration of resveratrol treatment and the use of a single-dose regimen may have limited its full car- dioprotective potential. We believe that future studies with larger sample sizes, extended treatment durations, multiple dosing strategies, and the incorporation of detailed molecu- lar and hemodynamic assessments are necessary to enhance the robustness of these findings.

    The Potential Protective Effects of Resveratrol Against Cabazitaxel-Induced Oxidative Stress and Cardiotoxicity in Rats · 2026 · DOI

  • (Ng et al., 2013). Conventional interventions often carry adverse effects (Wang et al., 2024), driving interest in alternative therapies, particularly medicinal plants, as potential treatments for the multifactorial pathogenesis of DR (Yong et al., 2025). Platycladus orientalis (L.) Franco, an evergreen conifer under the Cupressaceae family, has been used in traditional Chinese medicine for over 2,000 years (Shan et al., 2018). According to the classical text Shen Nong Ben Cao Jing, Platycladus orientalis is regarded as a top-grade medicinal herb traditionally used to alleviate paralysis, reduce palpitations, and promote longevity (Darwish et al., 2024). Recent pharmacological studies indicate that P. orientalis exerts protective effects against aging, diabetes, and neurodegenerative disorders (Sun et al., 2021; Yan et al., 2020). Specifically, leaf extracts exhibit neuroprotective effects by attenuating glutamate-induced neurotoxicity and suppressing mitochondrial-mediated neuronal apoptosis (Li X. et al., 2023). Collectively, these findings highlight the therapeutic potential of P. orientalis as a natural candidate for DR management. Lim et al. (2025) recently reported that P. orientalis inhibits angiogenesis in human retinal endothelial cells via the Raf- 1/MEK1/2 and AKT1/mTOR pathways. Building on this, the present study aims to investigate the role of AMPK as a central regulatory pathway and explores its interaction with VEGF- associated signaling, including mTOR/AKT1 and Raf-1/MEK1/2, in rMc-1. Unlike the previous focus on angiogenesis, this work provides new mechanistic insight into the neuroprotective effects of the ethyl acetate fraction of P. orientalis (EAPO) under diabetic-mimicking conditions. Specifically, this study evaluates its cytotoxicity and examines how AMPK modulation contributes to its neuroprotective and anti-neurodegenerative effects. This study hypothesizes that EAPO could mitigate high-glucose–induced cytotoxicity and enhance neuroprotection in rMc-1 via AMPK activation.

    Neuroprotective effects of Platycladus orientalis ethyl acetate fraction on retinal Müller cells: modulation of AKT1/mTOR and Raf-1/MEK1/2 pathways via AMPK activation · 2026 · DOI

  • This paper is a narrative synthesis and does not constitute a systematic review or meta-analysis. The clinical evidence base is evolving, and future long-duration trials may change benefit–risk assessments. Specific regulatory details vary by jurisdiction; this analysis emphasises internationally relevant public health principles and widely cited regulatory evidence. Finally, quantification of national healthcare costs attributable to NAD interventions requires dedicated health economic study.

    NAD⁺ Injections and NAD Boosters: Evidence Gaps, Safety Concerns, and Public Health Implications · 2026 · DOI

  • Despite numerous studies conducted to understand SIRT biology and its role in important cellular processes, many areas remain unexplored, such as the lack of SIRT-isoform selectivity and specificity, limited bioavailability, poor pharmacokinetic and pharmacodynamic properties, and the need for successful clinical trials for SIRT modulators.

    Elucidating binding hot spots and structural stability in sirtuin family proteins for selective inhibitors: a computational approach · 2026 · DOI

  • The formulation and bioavailability optimization of resveratrol for incorporation into functional foods and nutraceuticals requires investigation. Specific encapsulation methods, delivery systems, and stability parameters for resveratrol in food matrices targeting metabolic health in pre-diabetic and diabetic individuals remain unspecified.

    Assessment of the anti-diabetic potential of resveratrol in streptozotocin-induced diabetic animal models through modulation of oxidative stress and inflammation · 2026 · DOI

  • The long-term effects of resveratrol treatment on progression and reversal of renal structural anomalies (glomerular architecture disruption, tubular epithelial degeneration, fibrosis) in STZ-induced diabetic models need investigation. Current histopathological assessment (H&E staining) captures single time-point changes; longitudinal studies tracking fibrosis resolution and tissue regeneration over extended treatment periods are needed.

    Assessment of the anti-diabetic potential of resveratrol in streptozotocin-induced diabetic animal models through modulation of oxidative stress and inflammation · 2026 · DOI

  • The comparative efficacy of resveratrol versus other natural bioactive compounds (e.g., S. commune polysaccharides mentioned in the discussion) for modulating diabetes-related metabolic and renal complications remains unestablished. Head-to-head studies comparing resveratrol's effects on GLUT4 expression, GLP-1R restoration, and inflammatory biomarker reduction against alternative natural products are lacking.

    Assessment of the anti-diabetic potential of resveratrol in streptozotocin-induced diabetic animal models through modulation of oxidative stress and inflammation · 2026 · DOI

  • Clinical trial validation of resveratrol's anti-diabetic and renoprotective effects is needed. The current study uses only STZ-induced diabetic animal models; well-designed randomized controlled clinical trials must authenticate the efficiency and safety of resveratrol as a functional food ingredient or dietary supplement in human diabetic populations with varying glycemic control and renal function status.

    Assessment of the anti-diabetic potential of resveratrol in streptozotocin-induced diabetic animal models through modulation of oxidative stress and inflammation · 2026 · DOI

  • Dosage optimization and bioavailability enhancement of resveratrol require investigation. While the study demonstrated a dose-dependent trend at 25 mg/kg in STZ-induced diabetic rats, pharmacokinetic studies examining absorption, distribution, metabolism, and excretion rates, as well as optimal dosing strategies for human translation, are absent.

    Assessment of the anti-diabetic potential of resveratrol in streptozotocin-induced diabetic animal models through modulation of oxidative stress and inflammation · 2026 · DOI

  • The exact molecular mechanisms underlying resveratrol's modulatory effects on oxidative stress and inflammatory pathways in STZ-induced diabetic models require clarification. Specifically, the signaling cascades involving TNF-α suppression, IL-6 downregulation, and antioxidant enzyme activation (SOD, CAT, GST) need mechanistic elucidation beyond the current correlative findings.

    Assessment of the anti-diabetic potential of resveratrol in streptozotocin-induced diabetic animal models through modulation of oxidative stress and inflammation · 2026 · DOI

  • Further research employing oral administration at clinically relevant doses, alongside pharmacokinetic evaluations and larger sample sizes, is essential to confirm these findings and advance the clinical translation of RES.

    Mitigating methylparaben hepatotoxicity: Resveratrol’s role in oxidative stress, inflammation, and apoptotic modulation · 2026 · DOI

  • Future studies should use oral RES doses reflective of human intake and include pharmacokinetic evaluations to better assess its therapeutic potential against paraben-induced liver injury.

    Mitigating methylparaben hepatotoxicity: Resveratrol’s role in oxidative stress, inflammation, and apoptotic modulation · 2026 · DOI

  • The doses of MP and RES in this study were intentionally set at higher experimental levels, which may not reflect typical human outcomes due to interspecies differences in metabolism limiting direct clinical extrapolation.

    Mitigating methylparaben hepatotoxicity: Resveratrol’s role in oxidative stress, inflammation, and apoptotic modulation · 2026 · DOI

  • Although previous studies have shown profound effects of dietary RSV interventions on anti-obesity for decades, mechanisms underlying these benefi- cial effects remain elusive.

    Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation · 2024 · DOI

  • However, it remains to be elucidated how LCA extends lifespan in yeast, as it can benefit from LCA in terms of extending chronological lifespan72 even though it does not have conserved TULP3 orthologues.

    Lithocholic acid binds TULP3 to activate sirtuins and AMPK to slow down ageing · 2024 · DOI

  • LIMITATIONS, REASONS FOR CAUTION: The main limitation of this study was the absence of direct quantification of SIRT1 enzymatic activity due to the lack of an appropriately sensitive method.

    SIRT1 signalling protects mouse oocytes against oxidative stress and is deregulated during aging · 2014 · DOI

  • First, the precise upstream mechanisms driving ROS accumulation remain unclear and warrant further investigation.

    Valproic acid sensitizes resveratrol to induce glioma cell apoptosis via the ROS-PDCD4-Bax signaling axis · 2026 · DOI

  • ABSTRACT Resveratrol is widely studied for its anti‐inflammatory properties, yet the dose–response relationship between its molecular effects and potential organ toxicity in healthy animals remains poorly characterized.

    Dose‐Dependent Hepato–Renal Histopathology and Inflammatory Signaling Changes After Subacute Oral Resveratrol Exposure in Healthy Female Rats · 2026 · DOI

Most-cited papers in Sirtuins and Resveratrol in Medicine

Most recent work

Find a gap in your own Sirtuins and Resveratrol in Medicine sub-topic

This page shows what the Sirtuins and Resveratrol in Medicine literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Substance Abuse Treatment and Outcomes
989 open questions
Artificial Intelligence in Healthcare and Education
607 open questions
Attention Deficit Hyperactivity Disorder
448 open questions
Physical Activity and Health
436 open questions
Smoking Behavior and Cessation
402 open questions
Innovations in Medical Education
364 open questions
Dementia and Cognitive Impairment Research
363 open questions
HIV/AIDS Research and Interventions
342 open questions
27 open questions have been extracted from the limitations and future-work passages of 164 Sirtuins and Resveratrol in Medicine papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.